DHDennis Henzler

Dennis Henzler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dennis Henzler has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patients’ Perspectives on Applications of AI and Personalized Medicine in Life-Threatening Heart Disease: European Cross-Sectional Patient Questionnaire Study

    by Georg Ludwig Lindinger, Nicolas J Schiermeier, Dick L Willems, Menno Tom Maris, Mona Khattab, Hanno L Tan, Dennis Henzler, Marieke A R Bak, Eckhard Nagel, Michael Lauerer

    Background: The growing integration of personalized risk prediction (PRP) and AI substantially reshapes diagnostic and therapeutic decision-making in health care. At the same time, its responsible adoption depends not only on technical performance, but also on patients’ perspectives and acceptance. Objective: This study systematically examined patients’ perspectives across several European countries and explored how patients’ technology-related attitudes relate to their evaluations of personalized and AI-supported approaches in cardiac care. As part of the PROFID (Prevention of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation) project, its focus is on the ethical use of PRP and AI in the clinical context of decision-making regarding sudden cardiac death (SCD) prevention and implantable cardioverter-defibrillator (ICD) implantation. Methods: The study used a cross-sectional survey design with a standardized questionnaire including multimedia content. The target population comprised adults aged 18 years or older living in 6 European countries who met at least one of the following (self-reported) clinical criteria: heart failure, myocardial infarction (MI), cardiac arrest, or current ICD implantation. An exploratory factor analysis (EFA) was used to identify and evaluate internally consistent factors, and subsequent regression analyses examined associations between these factors and technological openness, sociodemographic characteristics, and patients’ views on PRP and AI in cardiac care. Results: The sample consisted of 470 participants from Germany (n=210), the Netherlands (n=86), the United Kingdom (n=145), and 3 other European countries (n=29; Austria, Belgium, and Spain). Overall, 51.9% (244/470) of respondents were male and 48.1% (226/470) were female. The mean age of the sample was 61.12 (SD 12.62) years. The EFA showed six clearly interpretable factors: (1) perceived benefits and support of PRP models in medical decision-making (MDM), (2) perceived benefits and support of AI in MDM, (3) transparency expectations in algorithmic decision-making, (4) support for delegating decisions to algorithms, (5) self-reported AI literacy, and (6) preference for shared decision-making (SDM). The regression analysis showed the relations of technological readiness, self-reported AI literacy, support for delegation of decisions to algorithms, transparency expectations in algorithmic decision-making, preferences for SDM, educational attainment, gender, and age to find associations with patients’ perceived benefits and support of PRP or AI in MDM. Conclusions: The findings support existing assumptions while also highlighting additional aspects that should be considered if high-level technologies are used in decision-making processes related to ICD implantation. PRP and AI were generally perceived as useful tools to support decision-making regarding ICD indication, provided transparency is ensured and patients remain actively involved in the decision-making process. Mandatory use and full delegation to decision-making directly by AI were broadly rejected. The attributed acceptance of delegation to PRP models was significantly higher than AI. In summary, implementation should support empathetic communication, patient involvement, and individual and institutional responsibility.

  • Open Access

    Patients’ Perspectives on Applications of Artificial Intelligence and Personalized Medicine in Life-Threatening Heart Disease – PROFID PATIENT SURVEY STUDY (Preprint)

    by Georg Ludwig Lindinger, Nicolas J Schiermeier, Dick L Willems, Menno Tom Maris, Mona Khattab, Hanno L Tan, Dennis Henzler, Marieke A R Bak, Michael Lauerer, Eckhard Nagel

    BACKGROUND The growing integration of Personalized Risk Prediction (PRP) and Artificial Intelligence (AI) substantially re-shapes diagnostic and therapeutic decision-making in health care. At the same time, its responsible adoption depends not only on technical performance, but also on patients’ perspectives and acceptance. OBJECTIVE This study systematically examined patients’ perspectives across several European countries and explored how patients’ technology-related attitudes relate to their evaluations of personalized and AI-supported ap-proaches in cardiac care. As part of the PROFID (Prevention of Sudden Cardiac Death After Myocardial Infarc-tion by Defibrillator Implantation) project, its focus is on the ethical use of PRP and AI in the clinical context of decision-making regarding sudden cardiac death (SCD) prevention and implantable cardioverter-defibrillator (ICD) implantation. METHODS The study used a cross-sectional survey design with a standardized questionnaire including multimedia con-tent. The target population comprised adults aged 18 years or older living in six European countries who met at least one of the following (self-reported) clinical criteria: heart failure, myocardial infarction (MI), cardiac arrest, or current ICD implantation. An exploratory factor analysis (EFA) was used to identify and evaluate internally consistent scales, and subsequent regression analyses examined associations between these scales and technological openness, sociodemographic characteristics, and patients’ views on PRP and AI in cardiac care. RESULTS The sample consisted of 470 participants from Germany (n=210), the Netherlands (n=86), the United Kingdom (n=145), and three other European countries (n=29; Austria, Belgium, and Spain). Overall, 51.9% (244/470) of respondents were male and 48.1% (226/470) were female. The mean age of the sample was 61.12 (SD 12.62) years. The EFA showed six clearly interpretable factors: (1) Perceived benefits and support of PRP models in medical decision-making (MDM); (2) Perceived benefits and support of AI in MDM; (3) Transparency expectations in algorithmic decision-making; (4) Support for delegating decisions to algorithms; (5) Self-reported AI literacy and (6) Preference for shared decision-making (SDM). The regression analysis showed the relations of technologi-cal readiness, self-reported AI literacy, support for delegation of decisions to algorithms, transparency expecta-tions in algorithmic decision-making, preferences for SDM, and educational attainment to predict patients’ perceived benefits and support of PRP or AI in MDM. CONCLUSIONS The findings support existing assumptions while also highlighting additional aspects that should be considered if high-level technologies are used in decision-making processes related to ICD implantation. PRP and AI were generally perceived as useful tools to support decision-making regarding ICD indication, provided that trans-parency is ensured and patients remain actively involved in the decision-making process. Mandatory use and full delegation to decision-making directly by Al were broadly rejected. Generally, men showed more positive perceptions of the use of AI in MDM than women. The attributed acceptance of delegation to PRP models was significantly higher than AI.

  • Top Cited Papers
    Open Access

    Healthcare professionals’ perspectives on artificial intelligence in patient care: a systematic review of hindering and facilitating factors on different levels

    by Dennis Henzler, Sebastian Schmidt, Ayca Koçar, Sophie Herdegen, Georg L. Lindinger, Menno T. Maris, Marieke A. R. Bak, Dick L. Willems, Hanno L. Tan, Michael Lauerer, et al.

    Background: Artificial intelligence (AI) applications present opportunities to enhance the diagnosis, prognosis, and treatment of various diseases. To successfully integrate and utilize AI in healthcare, it is crucial to understand the perspectives of healthcare professionals and to address challenges they associate with AI adoption at an early stage. Therefore, the aim of this review is to provide a comprehensive overview of empirical studies that explore healthcare professionals’ perspectives on AI in healthcare. Methods: The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses framework. The databases MEDLINE, PsycINFO, and Web of Science were searched in the timeline of 2017 to 2024 using terms related to ‘healthcare professionals’, ‘artificial intelligence’, and ‘perspectives’. Eligible were peer-reviewed articles that employed quantitative, qualitative, or mixed-methods approaches. Extracted facilitating and hindering factors were analysed according to the dimensions of the socio-ecological model. Results: Our search yielded 4,499 articles published up to February 2024. After title abstract screening, 150 full-texts were assessed for eligibility, and 72 studies were ultimately included in our synthesis. The extracted perspectives on AI were thematically analyzed using the socioecological model in order to identify various levels of influence and to categorize them into facilitating and hindering factors. In total, we identified 49 facilitating and 43 hindering factors across all levels of the socioecological model. Conclusions: The findings from this review can serve as a foundation for developing guidelines for AI implementation adressing various stakeholders, from healthcare professionals to policymakers. Future research should focus on the empirical adoption of AI applications and, if possible, further examine the hindering factors associated with different types of AI.


  • Open Access

    Impact of C-level positions on hospital performance: a scoping review protocol

    by Dennis Henzler, Matthias Lukas Zuchowski, Mark Dominik Alscher, Eckhard Nagel

    Introduction The objective of this scoping review is to identify evidence of the impact of hospital managers in top management (c-suite) on hospital performance. Managers generally have various effects on organisational objectives of their organisations. In recent years, the healthcare sector has experienced alterations in hospital governance structures, together with the emergence of new c-suite positions, aligning more closely with those found in private organisations. Their impact on hospital performance (ie, quality of care) is not well known. This scoping review seeks to identify all the available evidence of their impact on the organisational objectives. This scoping review will include primary studies, reviews and commentaries that describe the impact of top management team members on organisational outcomes in a hospital setting. Methods and analysis The search strategy aims to locate both published and unpublished documents (ie, grey literature) using a three-step search strategy. An exploratory search of Medline and Google Scholar identified keywords and Medical Subject Headings terms. A second search of Medline (PubMed), Web of Science Core Collection, ScienceDirect, Business Source Premier (EBScoHost), JSTOR, BASE, Lens.org and the Google Search Engine will be performed. The scope of the search will cover 1990-present time using English search terms. Manual searching by two reviewers will be added to the search strategy. The identified documents will be independently screened, selected by two researchers and extracted by one researcher. The data are then presented in tables and graphics coupled with a descriptive summary. Ethics and dissemination As this study neither involves human participants nor unpublished secondary data, an ethics approval is not required. Findings will be disseminated through professional networks, conference presentations and publication in a scientific journal. Trial registration number The protocol was registered on the Open Science Framework (https://doi.org/10.17605/OSF.IO/EBKUP).


  • Open Access

    Klinisches Krisenmanagement im Krankenhaus – Kommunikation und Leadership als Schlüsselgrößen der organisationalen Resilienz

    by Matthias Lukas Zuchowski, Dennis Henzler, Michael Lauerer, Aydan Göller, Mia Jiming Yang, Johanna Flohr, Mark Dominik Alscher, Eckhard Nagel

    Zusammenfassung: Zielsetzung Die Studie untersucht Schlüsselfaktoren zur Bewältigung von Krisensituationen in einem Krankenhaus und leitet Empfehlungen zur Stärkung der organisationalen Resilienz ab. Methodik Zweistufige Umfrage unterteilt in Mitarbeitende (n=670) und Expert:innen (n=42) zu Erfolgsfaktoren und strategischen Empfehlungen zur Krisenbewältigung. Ergebnisse Organisationale Resilienz wird erheblich von Führungs- und Kommunikationsmaßnahmen beeinflusst. Auch der Aufbau einer modularen und flexiblen Gebäudeinfrastruktur, die Bevorratung wichtiger IT-Ressourcen, sowie ein robustes Zulieferernetzwerk können als wichtige Resilienzfaktoren betrachtet werden. Schlussfolgerung Führung und Resilienz stehen im engen Verhältnis zueinander. Infrastrukturelle Faktoren als Vorhalteleistung stehen im Spannungsverhältnis zur derzeitigen Krankenhausfinanzierungsmodellen.


  • Chirurgie im Spannungsfeld „Humanität-Ethik-Ökonomie“

    by E. Nagel, M. Lauerer, D. Henzler

    Zusammenfassung Hintergrund Der ökonomische Druck im Gesundheitswesen hat in den zurückliegenden Jahren spürbar zugenommen. Die sich manifestierende „Ökonomisierung in der Medizin“ wirft die Frage nach der Vereinbarkeit ärztlicher Pflichten mit den wirtschaftlichen Anreizen im Gesundheitssystem auf. Fragestellung Vor diesem Hintergrund analysiert der Beitrag Spannungsfelder im deutschen Gesundheitswesen und speziell in der Chirurgie. Zu den wesentlichen Fragestellungen gehören: Welche Konfliktlinien verlaufen zwischen ethischen Pflichten und ökonomischen Anforderungen, welche Orientierungsmöglichkeiten können auf der Makro- und Mikroebene zur Konfliktlösung beitragen? Material und Methoden Der Beitrag basiert auf der Analyse normativer Regelungen, Leitlinien und Stellungnahmen von Institutionen der Selbstverwaltung sowie multidisziplinärer Literatur – aus der Medizin, Medizinethik und Gesundheitsökonomie. Kernthemen des Spannungsfeldes „Humanität-Ethik-Ökonomie“ werden strukturiert aufbereitet und Handlungsoptionen abgeleitet. Ergebnisse und Diskussion Übergeordnete Rahmenbedingungen und von ihnen ausgehende Anreize dürfen nicht mit ethischen Grundsätzen ärztlichen Handelns, besonders der primären Orientierung am Patientenwohl im Konflikt stehen. Institutionelle und individuelle Akteur*innen üben ihre Verantwortung zunächst gegenüber Patient*innen und nachrangig im Hinblick auf die sachgerechte, sparsame Verausgabung von Pflichtbeiträgen aus. Mit der medizinischen Versorgung von Menschen muss ein adäquates Auskommen möglich sein. Institutionelle Gewinnmaximierung verbietet sich – besonders für Finanzinvestoren. In der Corona-Pandemie werden ökonomische Fehlanreize deutlich und Nachjustierungen erforderlich. Handlungsoptionen zeigen sich in der Befähigung von Ärzteschaft und Management zu einem qualifizierten Austausch.